Covid-19 Impact on Biotherapeutics Cell Line Development Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Biotherapeutics Cell Line Development, including the following market information:
Major competitors identified in this market include Becton Dickinson & Company, Beckman Coulter, Boehringer Ingelheim Group, Catalent Inc., CMC Biologics A/S, Lonza Group Ltd., EMD Millipore, Partec (Sysmex Corporation), ProBioGen AG, Selexis SA, Sigma-Aldrich Co. LLC., Sony Biotechnology Inc., Thermo Fisher Scientific Inc., etc.
Based on the Region:
- Global Biotherapeutics Cell Line Development Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Biotherapeutics Cell Line Development Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Biotherapeutics Cell Line Development Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Biotherapeutics Cell Line Development Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Becton Dickinson & Company, Beckman Coulter, Boehringer Ingelheim Group, Catalent Inc., CMC Biologics A/S, Lonza Group Ltd., EMD Millipore, Partec (Sysmex Corporation), ProBioGen AG, Selexis SA, Sigma-Aldrich Co. LLC., Sony Biotechnology Inc., Thermo Fisher Scientific Inc., etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Transfection & Selection
- Single Cell Cloning
- In-house
- Outsource
- Hybrid
- Do-It-Yourself (DIY)
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Biotherapeutics Cell Line Development Industry
1.7 COVID-19 Impact: Biotherapeutics Cell Line Development Market Trends
2 GLOBAL BIOTHERAPEUTICS CELL LINE DEVELOPMENT QUARTERLY MARKET SIZE ANALYSIS
2.1 Biotherapeutics Cell Line Development Business Impact Assessment - COVID-19
2.1.1 Global Biotherapeutics Cell Line Development Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Biotherapeutics Cell Line Development Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Biotherapeutics Cell Line Development Quarterly Market Size, 2019 VS 2020
3.2 By Players, Biotherapeutics Cell Line Development Headquarters and Area Served
3.3 Date of Key Players Enter into Biotherapeutics Cell Line Development Market
3.4 Key Players Biotherapeutics Cell Line Development Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON BIOTHERAPEUTICS CELL LINE DEVELOPMENT SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Transfection & Selection
1.4.2 Single Cell Cloning
4.2 By Type, Global Biotherapeutics Cell Line Development Market Size, 2019-2021
5 IMPACT OF COVID-19 ON BIOTHERAPEUTICS CELL LINE DEVELOPMENT SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 In-house
5.5.2 Outsource
5.5.3 Hybrid
5.5.4 Do-It-Yourself (DIY)
5.2 By Application, Global Biotherapeutics Cell Line Development Market Size, 2019-2021
5.2.1 By Application, Global Biotherapeutics Cell Line Development Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Becton Dickinson & Company
7.1.1 Becton Dickinson & Company Business Overview
7.1.2 Becton Dickinson & Company Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.1.3 Becton Dickinson & Company Biotherapeutics Cell Line Development Product Introduction
7.1.4 Becton Dickinson & Company Response to COVID-19 and Related Developments
7.2 Beckman Coulter
7.2.1 Beckman Coulter Business Overview
7.2.2 Beckman Coulter Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.2.3 Beckman Coulter Biotherapeutics Cell Line Development Product Introduction
7.2.4 Beckman Coulter Response to COVID-19 and Related Developments
7.3 Boehringer Ingelheim Group
7.3.1 Boehringer Ingelheim Group Business Overview
7.3.2 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.3.3 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Product Introduction
7.3.4 Boehringer Ingelheim Group Response to COVID-19 and Related Developments
7.4 Catalent Inc.
7.4.1 Catalent Inc. Business Overview
7.4.2 Catalent Inc. Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.4.3 Catalent Inc. Biotherapeutics Cell Line Development Product Introduction
7.4.4 Catalent Inc. Response to COVID-19 and Related Developments
7.5 CMC Biologics A/S
7.5.1 CMC Biologics A/S Business Overview
7.5.2 CMC Biologics A/S Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.5.3 CMC Biologics A/S Biotherapeutics Cell Line Development Product Introduction
7.5.4 CMC Biologics A/S Response to COVID-19 and Related Developments
7.6 Lonza Group Ltd.
7.6.1 Lonza Group Ltd. Business Overview
7.6.2 Lonza Group Ltd. Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.6.3 Lonza Group Ltd. Biotherapeutics Cell Line Development Product Introduction
7.6.4 Lonza Group Ltd. Response to COVID-19 and Related Developments
7.7 EMD Millipore
7.7.1 EMD Millipore Business Overview
7.7.2 EMD Millipore Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.7.3 EMD Millipore Biotherapeutics Cell Line Development Product Introduction
7.7.4 EMD Millipore Response to COVID-19 and Related Developments
7.8 Partec (Sysmex Corporation)
7.8.1 Partec (Sysmex Corporation) Business Overview
7.8.2 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.8.3 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Product Introduction
7.8.4 Partec (Sysmex Corporation) Response to COVID-19 and Related Developments
7.9 ProBioGen AG
7.9.1 ProBioGen AG Business Overview
7.9.2 ProBioGen AG Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.9.3 ProBioGen AG Biotherapeutics Cell Line Development Product Introduction
7.9.4 ProBioGen AG Response to COVID-19 and Related Developments
7.10 Selexis SA
7.10.1 Selexis SA Business Overview
7.10.2 Selexis SA Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.10.3 Selexis SA Biotherapeutics Cell Line Development Product Introduction
7.10.4 Selexis SA Response to COVID-19 and Related Developments
7.11 Sigma-Aldrich Co. LLC.
7.11.1 Sigma-Aldrich Co. LLC. Business Overview
7.11.2 Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.11.3 Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Product Introduction
7.11.4 Sigma-Aldrich Co. LLC. Response to COVID-19 and Related Developments
7.12 Sony Biotechnology Inc.
7.12.1 Sony Biotechnology Inc. Business Overview
7.12.2 Sony Biotechnology Inc. Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.12.3 Sony Biotechnology Inc. Biotherapeutics Cell Line Development Product Introduction
7.12.4 Sony Biotechnology Inc. Response to COVID-19 and Related Developments
7.13 Thermo Fisher Scientific Inc.
7.13.1 Thermo Fisher Scientific Inc. Business Overview
7.13.2 Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.13.3 Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Product Introduction
7.13.4 Thermo Fisher Scientific Inc. Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Biotherapeutics Cell Line Development Industry
1.7 COVID-19 Impact: Biotherapeutics Cell Line Development Market Trends
2 GLOBAL BIOTHERAPEUTICS CELL LINE DEVELOPMENT QUARTERLY MARKET SIZE ANALYSIS
2.1 Biotherapeutics Cell Line Development Business Impact Assessment - COVID-19
2.1.1 Global Biotherapeutics Cell Line Development Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Biotherapeutics Cell Line Development Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Biotherapeutics Cell Line Development Quarterly Market Size, 2019 VS 2020
3.2 By Players, Biotherapeutics Cell Line Development Headquarters and Area Served
3.3 Date of Key Players Enter into Biotherapeutics Cell Line Development Market
3.4 Key Players Biotherapeutics Cell Line Development Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON BIOTHERAPEUTICS CELL LINE DEVELOPMENT SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Transfection & Selection
1.4.2 Single Cell Cloning
4.2 By Type, Global Biotherapeutics Cell Line Development Market Size, 2019-2021
5 IMPACT OF COVID-19 ON BIOTHERAPEUTICS CELL LINE DEVELOPMENT SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 In-house
5.5.2 Outsource
5.5.3 Hybrid
5.5.4 Do-It-Yourself (DIY)
5.2 By Application, Global Biotherapeutics Cell Line Development Market Size, 2019-2021
5.2.1 By Application, Global Biotherapeutics Cell Line Development Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Becton Dickinson & Company
7.1.1 Becton Dickinson & Company Business Overview
7.1.2 Becton Dickinson & Company Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.1.3 Becton Dickinson & Company Biotherapeutics Cell Line Development Product Introduction
7.1.4 Becton Dickinson & Company Response to COVID-19 and Related Developments
7.2 Beckman Coulter
7.2.1 Beckman Coulter Business Overview
7.2.2 Beckman Coulter Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.2.3 Beckman Coulter Biotherapeutics Cell Line Development Product Introduction
7.2.4 Beckman Coulter Response to COVID-19 and Related Developments
7.3 Boehringer Ingelheim Group
7.3.1 Boehringer Ingelheim Group Business Overview
7.3.2 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.3.3 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Product Introduction
7.3.4 Boehringer Ingelheim Group Response to COVID-19 and Related Developments
7.4 Catalent Inc.
7.4.1 Catalent Inc. Business Overview
7.4.2 Catalent Inc. Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.4.3 Catalent Inc. Biotherapeutics Cell Line Development Product Introduction
7.4.4 Catalent Inc. Response to COVID-19 and Related Developments
7.5 CMC Biologics A/S
7.5.1 CMC Biologics A/S Business Overview
7.5.2 CMC Biologics A/S Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.5.3 CMC Biologics A/S Biotherapeutics Cell Line Development Product Introduction
7.5.4 CMC Biologics A/S Response to COVID-19 and Related Developments
7.6 Lonza Group Ltd.
7.6.1 Lonza Group Ltd. Business Overview
7.6.2 Lonza Group Ltd. Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.6.3 Lonza Group Ltd. Biotherapeutics Cell Line Development Product Introduction
7.6.4 Lonza Group Ltd. Response to COVID-19 and Related Developments
7.7 EMD Millipore
7.7.1 EMD Millipore Business Overview
7.7.2 EMD Millipore Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.7.3 EMD Millipore Biotherapeutics Cell Line Development Product Introduction
7.7.4 EMD Millipore Response to COVID-19 and Related Developments
7.8 Partec (Sysmex Corporation)
7.8.1 Partec (Sysmex Corporation) Business Overview
7.8.2 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.8.3 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Product Introduction
7.8.4 Partec (Sysmex Corporation) Response to COVID-19 and Related Developments
7.9 ProBioGen AG
7.9.1 ProBioGen AG Business Overview
7.9.2 ProBioGen AG Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.9.3 ProBioGen AG Biotherapeutics Cell Line Development Product Introduction
7.9.4 ProBioGen AG Response to COVID-19 and Related Developments
7.10 Selexis SA
7.10.1 Selexis SA Business Overview
7.10.2 Selexis SA Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.10.3 Selexis SA Biotherapeutics Cell Line Development Product Introduction
7.10.4 Selexis SA Response to COVID-19 and Related Developments
7.11 Sigma-Aldrich Co. LLC.
7.11.1 Sigma-Aldrich Co. LLC. Business Overview
7.11.2 Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.11.3 Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Product Introduction
7.11.4 Sigma-Aldrich Co. LLC. Response to COVID-19 and Related Developments
7.12 Sony Biotechnology Inc.
7.12.1 Sony Biotechnology Inc. Business Overview
7.12.2 Sony Biotechnology Inc. Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.12.3 Sony Biotechnology Inc. Biotherapeutics Cell Line Development Product Introduction
7.12.4 Sony Biotechnology Inc. Response to COVID-19 and Related Developments
7.13 Thermo Fisher Scientific Inc.
7.13.1 Thermo Fisher Scientific Inc. Business Overview
7.13.2 Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Quarterly Revenue, 2020
7.13.3 Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Product Introduction
7.13.4 Thermo Fisher Scientific Inc. Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Biotherapeutics Cell Line Development Assessment
Table 9. COVID-19 Impact: Biotherapeutics Cell Line Development Market Trends
Table 10. COVID-19 Impact Global Biotherapeutics Cell Line Development Market Size
Table 11. Global Biotherapeutics Cell Line Development Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Biotherapeutics Cell Line Development Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Biotherapeutics Cell Line Development Market Growth Drivers
Table 14. Global Biotherapeutics Cell Line Development Market Restraints
Table 15. Global Biotherapeutics Cell Line Development Market Opportunities
Table 16. Global Biotherapeutics Cell Line Development Market Challenges
Table 17. By Players, Biotherapeutics Cell Line Development Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Biotherapeutics Cell Line Development Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Biotherapeutics Cell Line Development Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Biotherapeutics Cell Line Development Market
Table 21. Key Players Biotherapeutics Cell Line Development Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Biotherapeutics Cell Line Development Market Size 2019-2021, (US$ Million)
Table 24. Global Biotherapeutics Cell Line Development Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Biotherapeutics Cell Line Development Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 57. Becton Dickinson & Company Business Overview
Table 58. Becton Dickinson & Company Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Becton Dickinson & Company Biotherapeutics Cell Line Development Product
Table 60. Becton Dickinson & Company Response to COVID-19 and Related Developments
Table 61. Beckman Coulter Business Overview
Table 62. Beckman Coulter Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Beckman Coulter Biotherapeutics Cell Line Development Product
Table 64. Beckman Coulter Response to COVID-19 and Related Developments
Table 65. Boehringer Ingelheim Group Business Overview
Table 66. Boehringer Ingelheim Group Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Boehringer Ingelheim Group Biotherapeutics Cell Line Development Product
Table 68. Boehringer Ingelheim Group Response to COVID-19 and Related Developments
Table 69. Catalent Inc. Business Overview
Table 70. Catalent Inc. Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Catalent Inc. Biotherapeutics Cell Line Development Product
Table 72. Catalent Inc. Response to COVID-19 and Related Developments
Table 73. CMC Biologics A/S Business Overview
Table 74. CMC Biologics A/S Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. CMC Biologics A/S Biotherapeutics Cell Line Development Product
Table 76. CMC Biologics A/S Response to COVID-19 and Related Developments
Table 77. Lonza Group Ltd. Business Overview
Table 78. Lonza Group Ltd. Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Lonza Group Ltd. Biotherapeutics Cell Line Development Product
Table 80. Lonza Group Ltd. Response to COVID-19 and Related Developments
Table 81. EMD Millipore Business Overview
Table 82. EMD Millipore Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. EMD Millipore Biotherapeutics Cell Line Development Product
Table 84. EMD Millipore Response to COVID-19 and Related Developments
Table 85. Partec (Sysmex Corporation) Business Overview
Table 86. Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Product
Table 88. Partec (Sysmex Corporation) Response to COVID-19 and Related Developments
Table 89. ProBioGen AG Business Overview
Table 90. ProBioGen AG Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. ProBioGen AG Biotherapeutics Cell Line Development Product
Table 92. ProBioGen AG Response to COVID-19 and Related Developments
Table 93. Selexis SA Business Overview
Table 94. Selexis SA Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Selexis SA Biotherapeutics Cell Line Development Product
Table 96. Selexis SA Response to COVID-19 and Related Developments
Table 97. Sigma-Aldrich Co. LLC. Business Overview
Table 98. Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Product
Table 100. Sigma-Aldrich Co. LLC. Response to COVID-19 and Related Developments
Table 101. Sony Biotechnology Inc. Business Overview
Table 102. Sony Biotechnology Inc. Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Sony Biotechnology Inc. Biotherapeutics Cell Line Development Product
Table 104. Sony Biotechnology Inc. Response to COVID-19 and Related Developments
Table 105. Thermo Fisher Scientific Inc. Business Overview
Table 106. Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Product
Table 108. Thermo Fisher Scientific Inc. Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Biotherapeutics Cell Line Development Assessment
Table 9. COVID-19 Impact: Biotherapeutics Cell Line Development Market Trends
Table 10. COVID-19 Impact Global Biotherapeutics Cell Line Development Market Size
Table 11. Global Biotherapeutics Cell Line Development Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Biotherapeutics Cell Line Development Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Biotherapeutics Cell Line Development Market Growth Drivers
Table 14. Global Biotherapeutics Cell Line Development Market Restraints
Table 15. Global Biotherapeutics Cell Line Development Market Opportunities
Table 16. Global Biotherapeutics Cell Line Development Market Challenges
Table 17. By Players, Biotherapeutics Cell Line Development Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Biotherapeutics Cell Line Development Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Biotherapeutics Cell Line Development Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Biotherapeutics Cell Line Development Market
Table 21. Key Players Biotherapeutics Cell Line Development Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Biotherapeutics Cell Line Development Market Size 2019-2021, (US$ Million)
Table 24. Global Biotherapeutics Cell Line Development Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Biotherapeutics Cell Line Development Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Biotherapeutics Cell Line Development Market Size, 2019-2021 (US$ Million)
Table 57. Becton Dickinson & Company Business Overview
Table 58. Becton Dickinson & Company Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Becton Dickinson & Company Biotherapeutics Cell Line Development Product
Table 60. Becton Dickinson & Company Response to COVID-19 and Related Developments
Table 61. Beckman Coulter Business Overview
Table 62. Beckman Coulter Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Beckman Coulter Biotherapeutics Cell Line Development Product
Table 64. Beckman Coulter Response to COVID-19 and Related Developments
Table 65. Boehringer Ingelheim Group Business Overview
Table 66. Boehringer Ingelheim Group Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Boehringer Ingelheim Group Biotherapeutics Cell Line Development Product
Table 68. Boehringer Ingelheim Group Response to COVID-19 and Related Developments
Table 69. Catalent Inc. Business Overview
Table 70. Catalent Inc. Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Catalent Inc. Biotherapeutics Cell Line Development Product
Table 72. Catalent Inc. Response to COVID-19 and Related Developments
Table 73. CMC Biologics A/S Business Overview
Table 74. CMC Biologics A/S Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. CMC Biologics A/S Biotherapeutics Cell Line Development Product
Table 76. CMC Biologics A/S Response to COVID-19 and Related Developments
Table 77. Lonza Group Ltd. Business Overview
Table 78. Lonza Group Ltd. Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Lonza Group Ltd. Biotherapeutics Cell Line Development Product
Table 80. Lonza Group Ltd. Response to COVID-19 and Related Developments
Table 81. EMD Millipore Business Overview
Table 82. EMD Millipore Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. EMD Millipore Biotherapeutics Cell Line Development Product
Table 84. EMD Millipore Response to COVID-19 and Related Developments
Table 85. Partec (Sysmex Corporation) Business Overview
Table 86. Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Product
Table 88. Partec (Sysmex Corporation) Response to COVID-19 and Related Developments
Table 89. ProBioGen AG Business Overview
Table 90. ProBioGen AG Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. ProBioGen AG Biotherapeutics Cell Line Development Product
Table 92. ProBioGen AG Response to COVID-19 and Related Developments
Table 93. Selexis SA Business Overview
Table 94. Selexis SA Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Selexis SA Biotherapeutics Cell Line Development Product
Table 96. Selexis SA Response to COVID-19 and Related Developments
Table 97. Sigma-Aldrich Co. LLC. Business Overview
Table 98. Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Product
Table 100. Sigma-Aldrich Co. LLC. Response to COVID-19 and Related Developments
Table 101. Sony Biotechnology Inc. Business Overview
Table 102. Sony Biotechnology Inc. Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Sony Biotechnology Inc. Biotherapeutics Cell Line Development Product
Table 104. Sony Biotechnology Inc. Response to COVID-19 and Related Developments
Table 105. Thermo Fisher Scientific Inc. Business Overview
Table 106. Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Product
Table 108. Thermo Fisher Scientific Inc. Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Biotherapeutics Cell Line Development Product Picture
Figure 2. Biotherapeutics Cell Line Development Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Biotherapeutics Cell Line Development Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Biotherapeutics Cell Line Development Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Biotherapeutics Cell Line Development Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Biotherapeutics Cell Line Development Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Biotherapeutics Cell Line Development Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Biotherapeutics Cell Line Development Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Biotherapeutics Cell Line Development Market Size Market Share, 2019-2021
Figure 1. Biotherapeutics Cell Line Development Product Picture
Figure 2. Biotherapeutics Cell Line Development Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Biotherapeutics Cell Line Development Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Biotherapeutics Cell Line Development Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Biotherapeutics Cell Line Development Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Biotherapeutics Cell Line Development Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Biotherapeutics Cell Line Development Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Biotherapeutics Cell Line Development Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Biotherapeutics Cell Line Development Market Size Market Share, 2019-2021
